VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+2.93%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$182M
AUM Growth
+$182M
(-5.1%)
Cap. Flow
-$9.35M
Cap. Flow
% of AUM
-5.14%
Top 10 Holdings %
Top 10 Hldgs %
6.2%
Holding
508
New
65
Increased
160
Reduced
215
Closed
68
Top Buys
| 1 |
Dow Inc
DOW
|
$1.16M |
| 2 |
Hershey
HSY
|
$1.04M |
| 3 |
Copart
CPRT
|
$1.03M |
| 4 |
lululemon athletica
LULU
|
$1.02M |
| 5 |
Progressive
PGR
|
$999K |
Top Sells
| 1 |
Lennar Class A
LEN
|
$952K |
| 2 |
TJX Companies
TJX
|
$909K |
| 3 |
Ameriprise Financial
AMP
|
$902K |
| 4 |
Abbott
ABT
|
$892K |
| 5 |
Home Depot
HD
|
$885K |
Sector Composition
| 1 | Healthcare | 25.65% |
| 2 | Financials | 14.09% |
| 3 | Technology | 11.21% |
| 4 | Energy | 10.21% |
| 5 | Materials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Cassava Sciences
SAVA
$110M
| $55.2K | 0.03% |
2,288
-887
| -28% | -$21.4K |
|
427
Arcus Biosciences
RCUS
$1.15B
| $54.9K | 0.03% |
3,010
-1,156
| -28% | -$21.1K |
|
428
Adicet Bio
ACET
$61.1M
| $54.8K | 0.03% |
9,506
-3,658
| -28% | -$21.1K |
|
429
Sangamo Therapeutics
SGMO
$163M
| $51.6K | 0.03% |
29,327
-11,273
| -28% | -$19.8K |
|
430
PMV Pharmaceuticals
PMVP
$79M
| $49.7K | 0.03% |
10,422
-4,003
| -28% | -$19.1K |
|
431
Nkarta
NKTX
$149M
| $49.1K | 0.03% |
13,821
-5,314
| -28% | -$18.9K |
|
432
Inovio Pharmaceuticals
INO
$137M
| $44.4K | 0.02% |
54,106
-20,797
| -28% | -$17.1K |
|
433
Kezar Life Sciences
KZR
$28M
| $43.9K | 0.02% |
14,036
-5,391
| -28% | -$16.9K |
|
|
TVRD
434
Tvardi Therapeutics, Inc. Common Stock
TVRD
$277M
| $42.5K | 0.02% |
8,659
-3,323
| -28% | -$16.3K |
|
435
ALX Oncology
ALXO
$55.2M
| $40.8K | 0.02% |
9,019
-3,465
| -28% | -$15.7K |
|
436
Novavax
NVAX
$1.23B
| $40.7K | 0.02% |
5,873
-2,256
| -28% | -$15.6K |
|
437
Altimmune
ALT
$331M
| $39.6K | 0.02% |
9,389
-3,604
| -28% | -$15.2K |
|
438
C4 Therapeutics
CCCC
$179M
| $38.8K | 0.02% |
12,350
-4,752
| -28% | -$14.9K |
|
439
Fate Therapeutics
FATE
$119M
| $37.5K | 0.02% |
6,585
-2,528
| -28% | -$14.4K |
|
440
ImmunityBio
IBRX
$2.25B
| $27.3K | 0.02% |
15,009
-5,773
| -28% | -$10.5K |
|
441
Arbor Realty Trust
ABR
$2.25B
| – | – |
-31,669
| Closed | -$418K |
|
442
Apple
AAPL
$3.41T
| – | – |
-5,247
| Closed | -$682K |
|
|
443
Abbott
ABT
$229B
| – | – |
-8,125
| Closed | -$892K |
|
444
Accenture
ACN
$160B
| – | – |
-2,865
| Closed | -$764K |
|
445
Alamos Gold
AGI
$13.4B
| – | – |
-60,068
| Closed | -$607K |
|
|
446
Ameriprise Financial
AMP
$48.3B
| – | – |
-2,897
| Closed | -$902K |
|
447
Aon
AON
$80.2B
| – | – |
-2,760
| Closed | -$828K |
|
448
Algonquin Power & Utilities
AQN
$4.34B
| – | – |
-33,698
| Closed | -$220K |
|
449
Avista
AVA
$2.96B
| – | – |
-10,575
| Closed | -$469K |
|
450
AvalonBay Communities
AVB
$26.9B
| – | – |
-2,278
| Closed | -$368K |
|